APO Research
Talk to an analyst

APO RESEARCH · REPORT

Commercial Aquaculture Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Commercial Aquaculture Vaccines Market Outlook and Growth Opportunities 2026

31 December 2025197 pages

Choose your research edition.

Industry ResearchCommercial Aquaculture Vaccines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Commercial Aquaculture Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Commercial Aquaculture Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Commercial Aquaculture Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Commercial Aquaculture Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Commercial Aquaculture Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Commercial Aquaculture Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Commercial Aquaculture Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Commercial Aquaculture Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Commercial Aquaculture Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Commercial Aquaculture Vaccines market include Elanco Animal Health Inc, Ictyogroup, Laboratorios Hipra S. A., Merck & Co. Inc. (MSD Animal Health), Nisseiken Co Ltd, Tecnovax, Veterquimica S. A. and Zoetis LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Commercial Aquaculture Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Commercial Aquaculture Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Commercial Aquaculture Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Commercial Aquaculture Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Commercial Aquaculture Vaccines Segment by Company

Elanco Animal Health Inc

Ictyogroup

Laboratorios Hipra S. A.

Merck & Co. Inc. (MSD Animal Health)

Nisseiken Co Ltd

Tecnovax

Veterquimica S. A.

Zoetis LLC

Commercial Aquaculture Vaccines Segment by Type

Subunit Vaccine

Inactivated Vaccine

Live Attenuated Vaccine

Nucleic Acid Vaccine

Commercial Aquaculture Vaccines Segment by Application

Fisheries Research Institute

Breeding Clinic

Fisheries

Commercial Aquaculture Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Commercial Aquaculture Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Commercial Aquaculture Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Commercial Aquaculture Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Commercial Aquaculture Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Commercial Aquaculture Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Commercial Aquaculture Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Commercial Aquaculture Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Commercial Aquaculture Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Commercial Aquaculture Vaccines industry.

Chapter 3: Detailed analysis of Commercial Aquaculture Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Commercial Aquaculture Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Commercial Aquaculture Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Commercial Aquaculture Vaccines Industry Trends Table 2. Commercial Aquaculture Vaccines Industry Drivers Table 3. Commercial Aquaculture Vaccines Industry Opportunities and Challenges Table 4. Commercial Aquaculture Vaccines Industry Restraints Table 5. Global Commercial Aquaculture Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Commercial Aquaculture Vaccines Revenue Share by Company (2021-2026) Table 7. Global Commercial Aquaculture Vaccines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Commercial Aquaculture Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Commercial Aquaculture Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Commercial Aquaculture Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Commercial Aquaculture Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Commercial Aquaculture Vaccines Company, Product Type & Application Table 13. Global Commercial Aquaculture Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Commercial Aquaculture Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Subunit Vaccine Table 18. Significant Companies of Inactivated Vaccine Table 19. Significant Companies of Live Attenuated Vaccine Table 20. Significant Companies of Nucleic Acid Vaccine Table 21. Global Commercial Aquaculture Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Commercial Aquaculture Vaccines Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Commercial Aquaculture Vaccines Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Commercial Aquaculture Vaccines Sales Volume Share by Type (2021-2026) Table 25. Global Commercial Aquaculture Vaccines Sales Volume Share by Type (2027-2032) Table 26. Global Commercial Aquaculture Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Commercial Aquaculture Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Commercial Aquaculture Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Commercial Aquaculture Vaccines Sales Value Share by Type (2021-2026) Table 30. Global Commercial Aquaculture Vaccines Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Fisheries Research Institute Table 32. Significant Companies of Breeding Clinic Table 33. Significant Companies of Fisheries Table 34. Global Commercial Aquaculture Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Commercial Aquaculture Vaccines Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Commercial Aquaculture Vaccines Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Commercial Aquaculture Vaccines Sales Volume Share by Application (2021-2026) Table 38. Global Commercial Aquaculture Vaccines Sales Volume Share by Application (2027-2032) Table 39. Global Commercial Aquaculture Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Commercial Aquaculture Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Commercial Aquaculture Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Commercial Aquaculture Vaccines Sales Value Share by Application (2021-2026) Table 43. Global Commercial Aquaculture Vaccines Sales Value Share by Application (2027-2032) Table 44. Global Commercial Aquaculture Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Commercial Aquaculture Vaccines Sales by Region (2021-2026) & (K Units) Table 46. Global Commercial Aquaculture Vaccines Sales Market Share by Region (2021-2026) Table 47. Global Commercial Aquaculture Vaccines Sales by Region (2027-2032) & (K Units) Table 48. Global Commercial Aquaculture Vaccines Sales Market Share by Region (2027-2032) Table 49. Global Commercial Aquaculture Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Commercial Aquaculture Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Commercial Aquaculture Vaccines Sales Value Share by Region (2021-2026) Table 52. Global Commercial Aquaculture Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Commercial Aquaculture Vaccines Sales Value Share by Region (2027-2032) Table 54. Global Commercial Aquaculture Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Commercial Aquaculture Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Commercial Aquaculture Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Commercial Aquaculture Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Commercial Aquaculture Vaccines Sales by Country (2021-2026) & (K Units) Table 59. Global Commercial Aquaculture Vaccines Sales Market Share by Country (2021-2026) Table 60. Global Commercial Aquaculture Vaccines Sales by Country (2027-2032) & (K Units) Table 61. Global Commercial Aquaculture Vaccines Sales Market Share by Country (2027-2032) Table 62. Global Commercial Aquaculture Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Commercial Aquaculture Vaccines Sales Value Market Share by Country (2021-2026) Table 64. Global Commercial Aquaculture Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Commercial Aquaculture Vaccines Sales Value Market Share by Country (2027-2032) Table 66. Elanco Animal Health Inc Company Information Table 67. Elanco Animal Health Inc Business Overview Table 68. Elanco Animal Health Inc Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Elanco Animal Health Inc Commercial Aquaculture Vaccines Product Portfolio Table 70. Elanco Animal Health Inc Recent Development Table 71. Ictyogroup Company Information Table 72. Ictyogroup Business Overview Table 73. Ictyogroup Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Ictyogroup Commercial Aquaculture Vaccines Product Portfolio Table 75. Ictyogroup Recent Development Table 76. Laboratorios Hipra S. A. Company Information Table 77. Laboratorios Hipra S. A. Business Overview Table 78. Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Product Portfolio Table 80. Laboratorios Hipra S. A. Recent Development Table 81. Merck & Co. Inc. (MSD Animal Health) Company Information Table 82. Merck & Co. Inc. (MSD Animal Health) Business Overview Table 83. Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Product Portfolio Table 85. Merck & Co. Inc. (MSD Animal Health) Recent Development Table 86. Nisseiken Co Ltd Company Information Table 87. Nisseiken Co Ltd Business Overview Table 88. Nisseiken Co Ltd Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nisseiken Co Ltd Commercial Aquaculture Vaccines Product Portfolio Table 90. Nisseiken Co Ltd Recent Development Table 91. Tecnovax Company Information Table 92. Tecnovax Business Overview Table 93. Tecnovax Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Tecnovax Commercial Aquaculture Vaccines Product Portfolio Table 95. Tecnovax Recent Development Table 96. Veterquimica S. A. Company Information Table 97. Veterquimica S. A. Business Overview Table 98. Veterquimica S. A. Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Veterquimica S. A. Commercial Aquaculture Vaccines Product Portfolio Table 100. Veterquimica S. A. Recent Development Table 101. Zoetis LLC Company Information Table 102. Zoetis LLC Business Overview Table 103. Zoetis LLC Commercial Aquaculture Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Zoetis LLC Commercial Aquaculture Vaccines Product Portfolio Table 105. Zoetis LLC Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Commercial Aquaculture Vaccines Distributors List Table 109. Commercial Aquaculture Vaccines Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Commercial Aquaculture Vaccines Product Image Figure 2. Global Commercial Aquaculture Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Commercial Aquaculture Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Commercial Aquaculture Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Commercial Aquaculture Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Commercial Aquaculture Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Subunit Vaccine Image Figure 10. Inactivated Vaccine Image Figure 11. Live Attenuated Vaccine Image Figure 12. Nucleic Acid Vaccine Image Figure 13. Global Commercial Aquaculture Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Commercial Aquaculture Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Commercial Aquaculture Vaccines Sales Volume Share by Type (2021-2032) Figure 16. Global Commercial Aquaculture Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Commercial Aquaculture Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Commercial Aquaculture Vaccines Sales Value Share by Type (2021-2032) Figure 19. Fisheries Research Institute Image Figure 20. Breeding Clinic Image Figure 21. Fisheries Image Figure 22. Global Commercial Aquaculture Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Commercial Aquaculture Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Commercial Aquaculture Vaccines Sales Volume Share by Application (2021-2032) Figure 25. Global Commercial Aquaculture Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Commercial Aquaculture Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Commercial Aquaculture Vaccines Sales Value Share by Application (2021-2032) Figure 28. Global Commercial Aquaculture Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Commercial Aquaculture Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Commercial Aquaculture Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Commercial Aquaculture Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Commercial Aquaculture Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. North America Commercial Aquaculture Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Commercial Aquaculture Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Commercial Aquaculture Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Commercial Aquaculture Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Commercial Aquaculture Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Commercial Aquaculture Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. South America Commercial Aquaculture Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Commercial Aquaculture Vaccines Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Commercial Aquaculture Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Commercial Aquaculture Vaccines Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Commercial Aquaculture Vaccines Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Vaccine
  • Inactivated Vaccine
  • Live Attenuated Vaccine
  • Nucleic Acid Vaccine
Applications
  • Fisheries Research Institute
  • Breeding Clinic
  • Fisheries
Companies covered
  • Elanco Animal Health Inc
  • Ictyogroup
  • Laboratorios Hipra S. A.
  • Merck & Co. Inc. (MSD Animal Health)
  • Nisseiken Co Ltd
  • Tecnovax
  • Veterquimica S. A.
  • Zoetis LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Commercial Aquaculture Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Commercial Aquaculture Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Commercial Aquaculture Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Commercial Aquaculture Vaccines Market Dynamics
  1. 2.1 Commercial Aquaculture Vaccines Industry Trends
  2. 2.2 Commercial Aquaculture Vaccines Industry Drivers
  3. 2.3 Commercial Aquaculture Vaccines Industry Opportunities and Challenges
  4. 2.4 Commercial Aquaculture Vaccines Industry Restraints
3 Commercial Aquaculture Vaccines Market by Company
  1. 3.1 Global Commercial Aquaculture Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Commercial Aquaculture Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Commercial Aquaculture Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Commercial Aquaculture Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Commercial Aquaculture Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Commercial Aquaculture Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Commercial Aquaculture Vaccines Company Product Type and Application
  8. 3.8 Global Commercial Aquaculture Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Commercial Aquaculture Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Commercial Aquaculture Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Commercial Aquaculture Vaccines Market by Type
  1. 4.1 Commercial Aquaculture Vaccines Type Introduction
  2. 4.1.1 Subunit Vaccine
  3. 4.1.2 Inactivated Vaccine
  4. 4.1.3 Live Attenuated Vaccine
  5. 4.1.4 Nucleic Acid Vaccine
  6. 4.2 Global Commercial Aquaculture Vaccines Sales Volume by Type
  7. 4.2.1 Global Commercial Aquaculture Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Commercial Aquaculture Vaccines Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Commercial Aquaculture Vaccines Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Commercial Aquaculture Vaccines Sales Value by Type
  11. 4.3.1 Global Commercial Aquaculture Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Commercial Aquaculture Vaccines Sales Value by Type (2021-2032)
  13. 4.3.3 Global Commercial Aquaculture Vaccines Sales Value Share by Type (2021-2032)
5 Commercial Aquaculture Vaccines Market by Application
  1. 5.1 Commercial Aquaculture Vaccines Application Introduction
  2. 5.1.1 Fisheries Research Institute
  3. 5.1.2 Breeding Clinic
  4. 5.1.3 Fisheries
  5. 5.2 Global Commercial Aquaculture Vaccines Sales Volume by Application
  6. 5.2.1 Global Commercial Aquaculture Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Commercial Aquaculture Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Commercial Aquaculture Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Commercial Aquaculture Vaccines Sales Value by Application
  10. 5.3.1 Global Commercial Aquaculture Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Commercial Aquaculture Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Commercial Aquaculture Vaccines Sales Value Share by Application (2021-2032)
6 Commercial Aquaculture Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Commercial Aquaculture Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Commercial Aquaculture Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Commercial Aquaculture Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Commercial Aquaculture Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Commercial Aquaculture Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Commercial Aquaculture Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Commercial Aquaculture Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Commercial Aquaculture Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Commercial Aquaculture Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Commercial Aquaculture Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Commercial Aquaculture Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Commercial Aquaculture Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Commercial Aquaculture Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Commercial Aquaculture Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Commercial Aquaculture Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Commercial Aquaculture Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Commercial Aquaculture Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Commercial Aquaculture Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Commercial Aquaculture Vaccines Sales Value Share by Country, 2025 VS 2032
7 Commercial Aquaculture Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Commercial Aquaculture Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Commercial Aquaculture Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Commercial Aquaculture Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Commercial Aquaculture Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Commercial Aquaculture Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Commercial Aquaculture Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Commercial Aquaculture Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Commercial Aquaculture Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Commercial Aquaculture Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Commercial Aquaculture Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Commercial Aquaculture Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Elanco Animal Health Inc
  2. 8.1.1 Elanco Animal Health Inc Company Information
  3. 8.1.2 Elanco Animal Health Inc Business Overview
  4. 8.1.3 Elanco Animal Health Inc Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Elanco Animal Health Inc Commercial Aquaculture Vaccines Product Portfolio
  6. 8.1.5 Elanco Animal Health Inc Recent Developments
  7. 8.2 Ictyogroup
  8. 8.2.1 Ictyogroup Company Information
  9. 8.2.2 Ictyogroup Business Overview
  10. 8.2.3 Ictyogroup Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ictyogroup Commercial Aquaculture Vaccines Product Portfolio
  12. 8.2.5 Ictyogroup Recent Developments
  13. 8.3 Laboratorios Hipra S. A.
  14. 8.3.1 Laboratorios Hipra S. A. Company Information
  15. 8.3.2 Laboratorios Hipra S. A. Business Overview
  16. 8.3.3 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Product Portfolio
  18. 8.3.5 Laboratorios Hipra S. A. Recent Developments
  19. 8.4 Merck & Co. Inc. (MSD Animal Health)
  20. 8.4.1 Merck & Co. Inc. (MSD Animal Health) Company Information
  21. 8.4.2 Merck & Co. Inc. (MSD Animal Health) Business Overview
  22. 8.4.3 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Product Portfolio
  24. 8.4.5 Merck & Co. Inc. (MSD Animal Health) Recent Developments
  25. 8.5 Nisseiken Co Ltd
  26. 8.5.1 Nisseiken Co Ltd Company Information
  27. 8.5.2 Nisseiken Co Ltd Business Overview
  28. 8.5.3 Nisseiken Co Ltd Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nisseiken Co Ltd Commercial Aquaculture Vaccines Product Portfolio
  30. 8.5.5 Nisseiken Co Ltd Recent Developments
  31. 8.6 Tecnovax
  32. 8.6.1 Tecnovax Company Information
  33. 8.6.2 Tecnovax Business Overview
  34. 8.6.3 Tecnovax Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tecnovax Commercial Aquaculture Vaccines Product Portfolio
  36. 8.6.5 Tecnovax Recent Developments
  37. 8.7 Veterquimica S. A.
  38. 8.7.1 Veterquimica S. A. Company Information
  39. 8.7.2 Veterquimica S. A. Business Overview
  40. 8.7.3 Veterquimica S. A. Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Veterquimica S. A. Commercial Aquaculture Vaccines Product Portfolio
  42. 8.7.5 Veterquimica S. A. Recent Developments
  43. 8.8 Zoetis LLC
  44. 8.8.1 Zoetis LLC Company Information
  45. 8.8.2 Zoetis LLC Business Overview
  46. 8.8.3 Zoetis LLC Commercial Aquaculture Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zoetis LLC Commercial Aquaculture Vaccines Product Portfolio
  48. 8.8.5 Zoetis LLC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Commercial Aquaculture Vaccines Value Chain Analysis
  2. 9.1.1 Commercial Aquaculture Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Commercial Aquaculture Vaccines Sales Mode & Process
  6. 9.2 Commercial Aquaculture Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Commercial Aquaculture Vaccines Distributors
  9. 9.2.3 Commercial Aquaculture Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst